Roche burnishes breast cancer portfolio with FDA approval for Itovebi, a threat to Novartis and AZ
10th October 2024 Uncategorised 0 Roche burnishes breast cancer portfolio with FDA approval for Itovebi, a threat to Novartis and AZ
aliu
Thu, 10/10/2024 – 17:02
More: Roche burnishes breast cancer portfolio with FDA approval for Itovebi, a threat to Novartis and AZ
Source: fierce